PortfoliosLab logoPortfoliosLab logo
GILD vs. LAZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

GILD vs. LAZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Gilead Sciences, Inc. (GILD) and Lazard Ltd (LAZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, GILD achieves a 7.50% return, which is significantly higher than LAZ's -8.51% return. Both investments have delivered pretty close results over the past 10 years, with GILD having a 7.93% annualized return and LAZ not far ahead at 8.21%.


GILD

1D
0.05%
1M
4.38%
6M
2.19%
YTD
7.50%
1Y
21.39%
3Y*
21.28%
5Y*
17.78%
10Y*
7.93%
ALL TIME*
18.53%

LAZ

1D
0.16%
1M
-0.16%
6M
-17.49%
YTD
-8.51%
1Y
-15.69%
3Y*
11.90%
5Y*
4.72%
10Y*
8.21%
ALL TIME*
6.57%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$776.83M$985.51M$985.01M
$75.66M$81.64M$91.44M

GILD vs. LAZ - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
GILD
Gilead Sciences, Inc.
7.50%36.59%18.68%-1.99%23.63%29.95%-6.70%7.88%-9.92%2.96%
LAZ
Lazard Ltd
-8.51%-1.64%54.83%6.92%-16.21%7.41%12.08%15.22%-25.38%36.20%

Correlation

The correlation between GILD and LAZ is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.16

Correlation (5Y)
Calculated over the trailing 5-year period

0.21

Correlation (10Y)
Calculated over the trailing 10-year period

0.22

Correlation (All Time)
Calculated using the full available price history since May 5, 2005

0.29

Over the past year, the correlation between GILD and LAZ has dropped to 0.05 - well below their long-term average of 0.29, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

GILD:

$161.83B

LAZ:

$4.29B

EPS

GILD:

$7.35

LAZ:

$2.60

PE Ratio

GILD:

17.73

LAZ:

16.78

PS Ratio

GILD:

5.50

LAZ:

1.42

PB Ratio

GILD:

6.95

LAZ:

5.28

Total Revenue (TTM)

GILD:

$29.74B

LAZ:

$3.28B

Gross Profit (TTM)

GILD:

$18.74B

LAZ:

$1.54B

EBITDA (TTM)

GILD:

$12.88B

LAZ:

$477.61M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

GILD vs. LAZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GILD
GILD Risk / Return Rank: 6767
Overall Rank
GILD Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
GILD Sortino Ratio Rank: 6868
Sortino Ratio Rank
GILD Omega Ratio Rank: 6464
Omega Ratio Rank
GILD Calmar Ratio Rank: 6666
Calmar Ratio Rank
GILD Martin Ratio Rank: 6868
Martin Ratio Rank

LAZ
LAZ Risk / Return Rank: 2727
Overall Rank
LAZ Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
LAZ Sortino Ratio Rank: 2727
Sortino Ratio Rank
LAZ Omega Ratio Rank: 2828
Omega Ratio Rank
LAZ Calmar Ratio Rank: 2727
Calmar Ratio Rank
LAZ Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GILD vs. LAZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gilead Sciences, Inc. (GILD) and Lazard Ltd (LAZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


GILDLAZDifference
Sharpe ratioReturn per unit of total volatility

+1.18

Sortino ratioReturn per unit of downside risk

+1.68

Omega ratioGain probability vs. loss probability

1.15

0.96

+0.19

Calmar ratioReturn relative to maximum drawdown

1.00

-0.50

+1.50

Martin ratioReturn relative to average drawdown

2.34

-0.99

+3.33

GILD vs. LAZ - Sharpe Ratio Comparison

The current GILD Sharpe Ratio is 0.79, which is higher than the LAZ Sharpe Ratio of -0.39. The chart below compares the historical Sharpe Ratios of GILD and LAZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

GILD vs. LAZ - Drawdown Comparison

The maximum GILD drawdown since its inception was -70.83%, which is greater than LAZ's maximum drawdown of -62.72%. Use the drawdown chart below to compare losses from any high point for GILD and LAZ.


Loading charts...

Drawdown Indicators


GILDLAZDifference

Max Drawdown

Largest peak-to-trough decline

-70.83%

-62.72%

-8.11%

Max Drawdown (1Y)

Largest decline over 1 year

-21.59%

-31.39%

+9.80%

Max Drawdown (3Y)

Largest decline over 3 years

-26.59%

-44.24%

+17.65%

Max Drawdown (5Y)

Largest decline over 5 years

-26.59%

-44.24%

+17.65%

Max Drawdown (10Y)

Largest decline over 10 years

-30.47%

-59.51%

+29.04%

Current Drawdown

Current decline from peak

-15.31%

-23.41%

+8.10%

Average Drawdown

Average peak-to-trough decline

-22.14%

-23.50%

+1.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.16%

15.88%

-6.72%

Volatility

GILD vs. LAZ - Volatility Comparison

The current volatility for Gilead Sciences, Inc. (GILD) is 10.00%, while Lazard Ltd (LAZ) has a volatility of 13.02%. This indicates that GILD experiences smaller price fluctuations and is considered to be less risky than LAZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


GILDLAZDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.00%

13.02%

-3.02%

Volatility (6M)

Calculated over the trailing 6-month period

19.91%

34.41%

-14.50%

Volatility (1Y)

Calculated over the trailing 1-year period

27.30%

40.46%

-13.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.52%

37.65%

-13.13%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.60%

35.96%

-10.36%

Dividends

GILD vs. LAZ - Dividend Comparison

GILD's dividend yield for the trailing twelve months is around 2.47%, less than LAZ's 4.59% yield.


PositionTTM20252024202320222021202020192018201720162015
GILD
Gilead Sciences, Inc.
2.47%2.57%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%
LAZ
Lazard Ltd
4.59%4.12%3.89%5.75%5.60%4.31%4.44%5.88%8.21%5.35%6.55%5.22%

Financials

GILD vs. LAZ - Financials Comparison

This section allows you to compare key financial metrics between Gilead Sciences, Inc. and Lazard Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
6.96B
779.40M
(GILD) Total Revenue
(LAZ) Total Revenue
Values in USD except per share items

GILD vs. LAZ - Profitability Comparison

The chart below illustrates the profitability comparison between Gilead Sciences, Inc. and Lazard Ltd over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.1%
100.0%
Portfolio components
GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported a gross profit of 79.20M and revenue of 6.96B. Therefore, the gross margin over that period was 1.1%.

LAZ - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported a gross profit of 779.40M and revenue of 779.40M. Therefore, the gross margin over that period was 100.0%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported an operating income of 2.59B and revenue of 6.96B, resulting in an operating margin of 37.2%.

LAZ - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported an operating income of 112.39M and revenue of 779.40M, resulting in an operating margin of 14.4%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Gilead Sciences, Inc. reported a net income of 2.02B and revenue of 6.96B, resulting in a net margin of 29.0%.

LAZ - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Lazard Ltd reported a net income of 100.92M and revenue of 779.40M, resulting in a net margin of 13.0%.


Frequently Asked Questions


GILD and LAZ have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LAZ has higher volatility (13.02%) compared to GILD (10.00%). In terms of maximum drawdown, GILD dropped -70.83% vs LAZ's -62.72%.

GILD currently has the higher Sharpe Ratio (0.79 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for GILD and LAZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer